Get in-depth insights into the U.S. hormone refractory prostate cancer market, including key drivers such as rising disease prevalence, innovative therapeutic pipelines, and personalized treatment innovations. https://www.openpr.com/news/4318357/united-states-hormone-refractory-prostate-cancer-market